Daniele Bianchi
Download the ICS Branding Pack
Podium Short Oral Session 23 OAB from Laboratory to Clinic 199 Nervous system disorders related to anticholinergics and β3-agonists use: findings from the European Union Drug Regulatory Authorities (EUDRA) registry
Open Discussion Session 104 Open Discussion ePosters 516 Patient perception and tolerability during urodynamics: highlights from the literature
Podium Short Oral Session 18 Urology 7 - Clinical Neurourology 213 Clean intermittent catheterization (CIC): barriers and patient reluctance
Non Discussion Abstract Session 36 Non Discussion Abstracts 730 Intravesical botulinum toxin injections in an office-based setting: patients' comfort and tolerability
ICS Committee Member
Dr Daniele Bianchi declared on the Wednesday 7th January 2026 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).
ICS Urodynamics Committee
Committee Member
ICI8 Chapter 03. Pathophysiology of UI, POP & FI
Podcast Development Taskforce